There is a study in rats [31] in which exendin-4 induces satiety and decreases ghrelin by 74%, and a report of a female PWS patient [32] in which liraglutide increases insulin and reduces GLP-1 and ghrelin concentrations. This evidence concerns the gene GLP1R and Prader-Willi syndrome.